Gregory John Hafner

Title: Gregory John Hafner: Innovator in Plant Biotechnology

Introduction

Gregory John Hafner is a notable inventor based in Wynnum, Australia. He has made significant contributions to the field of plant biotechnology, particularly through his innovative patents. With a total of six patents to his name, Hafner's work focuses on enhancing plant genetic engineering techniques.

Latest Patents

Hafner's latest patents include the invention of TaBV transcriptional control elements and chimeric constructs. This invention discloses a constitutive promoter derived from the Taro bacilliform virus (TaBV) for the expression of foreign or endogenous coding sequences in both dicotyledonous and monocotyledonous plants. The invention also details a chimeric nucleic acid construct that comprises the promoter operably linked to a foreign or endogenous polynucleotide, which codes for a protein of interest or a transcript capable of modulating the expression of a target gene. Furthermore, the invention reveals transformed plant cells, as well as differentiated plants and plant parts, that contain the construct. Additionally, methods for the diagnosis and treatment of viral infections, particularly badnaviral infections, are disclosed.

Career Highlights

Hafner has worked with prominent organizations such as Queensland University of Technology and Farmacule Bioindustries Pty Ltd. His experience in these institutions has allowed him to develop and refine his innovative ideas in plant biotechnology.

Collaborations

Some of his notable coworkers include James Langham Dale and Robert Maxwell Harding. Their collaborative efforts have contributed to advancing research in the field.

Conclusion

Gregory John Hafner's contributions to plant biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the field, paving the way for advancements in plant genetic engineering.